Solid Biosciences (SLDB) Restructuring Costs (2020 - 2023)
Solid Biosciences (SLDB) reported Restructuring Costs of -$63,000 for FY2023, compared with $7.18 million in FY2022.
Powered by 
Analysis
Solid Biosciences (SLDB) Restructuring Costs (2020 - 2023) Analysis & Trends
- According to Business Quant data, Restructuring Costs came in at $7.18 million in FY2022 and $1.94 million in FY2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Solid Biosciences | 1.05 Bn | 1.05 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -63,000.00 |
| Dec 31, 2022 | 5.66 Mn |
| Jun 30, 2022 | 1.52 Mn |
| Mar 31, 2020 | 1.94 Mn |
API Access
Solid Biosciences Restructuring Costs API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=restructuring-costs&ticker=SLDB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "restructuring-costs", "ticker": "SLDB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=restructuring-costs&ticker=SLDB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();